Valuation

PGNYProgyny Inc

StockNasdaqEstados UnidosHealth careEU retail: available

10/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	PGNY	Sector median	vs median
P/E	27,2	28,8 · n=114	6% below
P/B	4,7	3,0 · n=196	56% above
P/S	1,6	3,7 · n=202	56% below
EV/EBIT	16,9	24,1 · n=103	30% below
Free-cash-flow yield	8,4%	2,8% · n=187	198% above
Dividend yield	0,00%	0,00% · n=215	—
Return on equity	16,2%	2,7% · n=193	511% above
Return on invested capital	21,5%	3,5% · n=176	507% above
Gross margin	24,6%	62,5% · n=152	61% below
Net debt / EBITDA	−2,01	1,19 · n=108	269% below

Value factor: 91 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	42,6	33,6	—	1,6%	0,6%	6/10
JNJJohnson & Johnson	29,1	7,2	—	3,6%	2,1%	8/10
ABBVAbbVie	79,9	—	33,5	3,6%	3,0%	5/10
MRKMerck	114,6	8,7	—	4,4%	2,3%	8/10
UNHUnitedHealth	25,1	3,4	18,6	6,7%	2,3%	9/10
TMOThermo Fisher Scientific	35,7	4,7	35,2	2,9%	0,3%	8/10
AMGNAmgen	26,3	19,7	24,0	4,4%	2,3%	6/10
GILDGILEAD	—	16,1	—	6,8%	2,1%	4/10
ABTAbbott	28,5	3,4	26,8	4,1%	3,0%	5/10
PFEPfizer	38,4	2,0	—	6,6%	5,9%	1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 jun. 2026 · filed 07 ago. 2026

Cancelar contrato aqui · Consumidores da UE: 14 dias para desistir de uma compra.